世界のデガレリクス市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Degarelix Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5692 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・デガレリクスの市場動向 ・企業の競争状況、市場シェア ・デガレリクスの種類別市場規模と予測2016-2027（バイアル/120mg、バイアル/80mg） ・デガレリクスの用途別市場規模と予測2016-2027（病院、ドラッグストア） ・デガレリクスの北米市場規模2016-2027（アメリカ、カナダ） ・デガレリクスの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・デガレリクスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・デガレリクスの中南米市場規模2016-2027（メキシコ、ブラジル） ・デガレリクスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ferring） ・結論

Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer.

Market Analysis and Insights: Global Degarelix Market
The global Degarelix market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Degarelix market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Degarelix market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Degarelix market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Degarelix market.

Global Degarelix Scope and Market Size
Degarelix market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Degarelix market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
120 mg per vial
80 mg per vial

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ferring

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Degarelix Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 120 mg per vial
1.2.3 80 mg per vial
1.3 Market by Application
1.3.1 Global Degarelix Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Degarelix Market Perspective (2016-2027)
2.2 Degarelix Growth Trends by Regions
2.2.1 Degarelix Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Degarelix Historic Market Share by Regions (2016-2021)
2.2.3 Degarelix Forecasted Market Size by Regions (2022-2027)
2.3 Degarelix Industry Dynamic
2.3.1 Degarelix Market Trends
2.3.2 Degarelix Market Drivers
2.3.3 Degarelix Market Challenges
2.3.4 Degarelix Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Degarelix Players by Revenue
3.1.1 Global Top Degarelix Players by Revenue (2016-2021)
3.1.2 Global Degarelix Revenue Market Share by Players (2016-2021)
3.2 Global Degarelix Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Degarelix Revenue
3.4 Global Degarelix Market Concentration Ratio
3.4.1 Global Degarelix Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Degarelix Revenue in 2020
3.5 Degarelix Key Players Head office and Area Served
3.6 Key Players Degarelix Product Solution and Service
3.7 Date of Enter into Degarelix Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Degarelix Breakdown Data by Type
4.1 Global Degarelix Historic Market Size by Type (2016-2021)
4.2 Global Degarelix Forecasted Market Size by Type (2022-2027)

5 Degarelix Breakdown Data by Application
5.1 Global Degarelix Historic Market Size by Application (2016-2021)
5.2 Global Degarelix Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Degarelix Market Size (2016-2027)
6.2 North America Degarelix Market Size by Type
6.2.1 North America Degarelix Market Size by Type (2016-2021)
6.2.2 North America Degarelix Market Size by Type (2022-2027)
6.2.3 North America Degarelix Market Size by Type (2016-2027)
6.3 North America Degarelix Market Size by Application
6.3.1 North America Degarelix Market Size by Application (2016-2021)
6.3.2 North America Degarelix Market Size by Application (2022-2027)
6.3.3 North America Degarelix Market Size by Application (2016-2027)
6.4 North America Degarelix Market Size by Country
6.4.1 North America Degarelix Market Size by Country (2016-2021)
6.4.2 North America Degarelix Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Degarelix Market Size (2016-2027)
7.2 Europe Degarelix Market Size by Type
7.2.1 Europe Degarelix Market Size by Type (2016-2021)
7.2.2 Europe Degarelix Market Size by Type (2022-2027)
7.2.3 Europe Degarelix Market Size by Type (2016-2027)
7.3 Europe Degarelix Market Size by Application
7.3.1 Europe Degarelix Market Size by Application (2016-2021)
7.3.2 Europe Degarelix Market Size by Application (2022-2027)
7.3.3 Europe Degarelix Market Size by Application (2016-2027)
7.4 Europe Degarelix Market Size by Country
7.4.1 Europe Degarelix Market Size by Country (2016-2021)
7.4.2 Europe Degarelix Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Degarelix Market Size (2016-2027)
8.2 Asia-Pacific Degarelix Market Size by Type
8.2.1 Asia-Pacific Degarelix Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Degarelix Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Degarelix Market Size by Type (2016-2027)
8.3 Asia-Pacific Degarelix Market Size by Application
8.3.1 Asia-Pacific Degarelix Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Degarelix Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Degarelix Market Size by Application (2016-2027)
8.4 Asia-Pacific Degarelix Market Size by Region
8.4.1 Asia-Pacific Degarelix Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Degarelix Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Degarelix Market Size (2016-2027)
9.2 Latin America Degarelix Market Size by Type
9.2.1 Latin America Degarelix Market Size by Type (2016-2021)
9.2.2 Latin America Degarelix Market Size by Type (2022-2027)
9.2.3 Latin America Degarelix Market Size by Type (2016-2027)
9.3 Latin America Degarelix Market Size by Application
9.3.1 Latin America Degarelix Market Size by Application (2016-2021)
9.3.2 Latin America Degarelix Market Size by Application (2022-2027)
9.3.3 Latin America Degarelix Market Size by Application (2016-2027)
9.4 Latin America Degarelix Market Size by Country
9.4.1 Latin America Degarelix Market Size by Country (2016-2021)
9.4.2 Latin America Degarelix Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Degarelix Market Size (2016-2027)
10.2 Middle East & Africa Degarelix Market Size by Type
10.2.1 Middle East & Africa Degarelix Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Degarelix Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Degarelix Market Size by Type (2016-2027)
10.3 Middle East & Africa Degarelix Market Size by Application
10.3.1 Middle East & Africa Degarelix Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Degarelix Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Degarelix Market Size by Application (2016-2027)
10.4 Middle East & Africa Degarelix Market Size by Country
10.4.1 Middle East & Africa Degarelix Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Degarelix Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ferring
11.1.1 Ferring Company Details
11.1.2 Ferring Business Overview
11.1.3 Ferring Degarelix Introduction
11.1.4 Ferring Revenue in Degarelix Business (2016-2021)
11.1.5 Ferring Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Degarelix Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 120 mg per vial
Table 3. Key Players of 80 mg per vial
Table 4. Global Degarelix Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Degarelix Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Degarelix Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Degarelix Market Share by Regions (2016-2021)
Table 8. Global Degarelix Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Degarelix Market Share by Regions (2022-2027)
Table 10. Degarelix Market Trends
Table 11. Degarelix Market Drivers
Table 12. Degarelix Market Challenges
Table 13. Degarelix Market Restraints
Table 14. Global Degarelix Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Degarelix Market Share by Players (2016-2021)
Table 16. Global Top Degarelix Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Degarelix as of 2020)
Table 17. Ranking of Global Top Degarelix Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Degarelix Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Degarelix Product Solution and Service
Table 21. Date of Enter into Degarelix Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Degarelix Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Degarelix Revenue Market Share by Type (2016-2021)
Table 25. Global Degarelix Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Degarelix Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Degarelix Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Degarelix Revenue Market Share by Application (2016-2021)
Table 29. Global Degarelix Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Degarelix Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Degarelix Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Degarelix Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Degarelix Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Degarelix Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Degarelix Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Degarelix Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Degarelix Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Degarelix Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Degarelix Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Degarelix Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Degarelix Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Degarelix Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Degarelix Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Degarelix Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Degarelix Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Degarelix Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Degarelix Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Degarelix Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Degarelix Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Degarelix Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Degarelix Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Degarelix Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Degarelix Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Degarelix Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Degarelix Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Degarelix Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Degarelix Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Degarelix Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Degarelix Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Degarelix Market Size by Country (2022-2027) & (US$ Million)
Table 61. Ferring Company Details
Table 62. Ferring Business Overview
Table 63. Ferring Degarelix Product
Table 64. Ferring Revenue in Degarelix Business (2016-2021) & (US$ Million)
Table 65. Ferring Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Degarelix Market Share by Type: 2020 VS 2027
Figure 2. 120 mg per vial Features
Figure 3. 80 mg per vial Features
Figure 4. Global Degarelix Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Degarelix Report Years Considered
Figure 8. Global Degarelix Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Degarelix Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Degarelix Market Share by Regions: 2020 VS 2027
Figure 11. Global Degarelix Market Share by Regions (2022-2027)
Figure 12. Global Degarelix Market Share by Players in 2020
Figure 13. Global Top Degarelix Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Degarelix as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Degarelix Revenue in 2020
Figure 15. Global Degarelix Revenue Market Share by Type (2016-2021)
Figure 16. Global Degarelix Revenue Market Share by Type (2022-2027)
Figure 17. North America Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Degarelix Market Share by Type (2016-2027)
Figure 19. North America Degarelix Market Share by Application (2016-2027)
Figure 20. North America Degarelix Market Share by Country (2016-2027)
Figure 21. United States Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Degarelix Market Share by Type (2016-2027)
Figure 25. Europe Degarelix Market Share by Application (2016-2027)
Figure 26. Europe Degarelix Market Share by Country (2016-2027)
Figure 27. Germany Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Degarelix Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Degarelix Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Degarelix Market Share by Region (2016-2027)
Figure 37. China Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Degarelix Market Share by Type (2016-2027)
Figure 45. Latin America Degarelix Market Share by Application (2016-2027)
Figure 46. Latin America Degarelix Market Share by Country (2016-2027)
Figure 47. Mexico Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Degarelix Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Degarelix Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Degarelix Market Share by Country (2016-2027)
Figure 53. Turkey Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Degarelix Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Ferring Revenue Growth Rate in Degarelix Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

---